|
1. A randomized trial
of anticoagulants versus aspirin
after cerebral ischemia of
presumed arterial origin.
The Stroke Prevention in Reversible
Ischemia Trial (SPIRIT) Study
Group. Ann Neurol.
1997;42:857-865.
2. Albers GW. Choice
of endpoints in antiplatelet
trials: which outcomes are
most relevant to stroke patients?
Neurology. 2000;54:1022-1028.
3. Albers GW, Amarenco
P. Combination therapy with
clopidogrel and aspirin: can
the CURE results be extrapolated
to cerebrovascular patients?
Stroke. 2001;32:2948-2949.
4. Alberts MJ. Diagnosis
and treatment of ischemic
stroke. Am J Med. 1999;106:211-221.
5. Benavente O, Hart
RG, Kent T, et al. Secondary
prevention for small subcortical
strokes - pilot study [poster].
Poster presented at: American
Stroke Association of the
AHA 25th International Stroke
Conference; February 10-12,
2000; New Orleans, LA.
6. Bhatt DL, Bertrand
ME, Berger PB, et al. Meta-analysis
of randomized and registry
comparisons of ticlopidine
with clopidogrel after stenting.
J Am Coll Cardiol.
2002;39:9-14.
7. Bhatt DL, Chew
DP, Hirsch AT, Ringleb PA,
Hacke W, Topol EJ. Superiority
of clopidogrel versus aspirin
in patients with prior cardiac
surgery. Circulation.
2001;103:363-368.
8. Bhatt DL, Hirsch
AT, Ringleb PA, Hacke W, Topol
EJ, on behalf of the CAPRIE
investigators. Reduction in
the need for hospitalization
for recurrent ischemic events
and bleeding with clopidogrel
instead of aspirin. Am
Heart J. 2000;140:67-73.
9. Bhatt DL, Kapadia
SR, Bajzer CT, et al. Dual
antiplatelet therapy with
clopidogrel and aspirin after
carotid artery stenting. J
Invasive Cardiol. 2001;13:767-771.
10. Boysen G, Truelsen
T. Prevention of recurrent
stroke. Neurolog Sci.
2000;21:67-72.
11. Brass LM. Advances
in long-term stroke prevention
with antiplatelet therapy.
Journal of Stroke and Cerebrovascular
Diseases. 2001;10:18-23.
12. Brass LM, Lichtman
JH, Wang Y, Gurwitz JH, Radford
MJ, Krumholz HM. Intracranial
hemorrhage associated with
thrombolytic therapy for elderly
patients with acute myocardial
infarction: results from the
Cooperative Cardiovascular
Project. Stroke. 2000;31:1802-1811.
13. CAPRIE Steering
Committee. A randomised, blinded,
trial of clopidogrel versus
aspirin in patients at risk
of ischaemic events (CAPRIE).
Lancet. 1996;348:1329-1339.
14. Chaturvedi S, Hickenbottom
S, Levine SR. Ischemic stroke
prevention. Curr Treat
Options Neurol. 1999;1:113-126.
15. Chew DP, Bhatt
DL, Robbins MA, et al. Effect
of clopidogrel added to aspirin
before percutaneous coronary
intervention on the risk associated
with C-reactive protein. Am
J Cardiol. 2001;88:672-674.
16. CURE Study Investigators.
The Clopidogrel in Unstable
angina to prevent Recurrent
Events (CURE) trial programme;
rationale, design and baseline
characteristics including
a meta-analysis of the effects
of thienopyridines in vascular
disease. Eur Heart J.
2000;21:2033-2041.
17. De Schryver ELLM.
Design of ESPRIT: An international
randomized trial for secondary
prevention after non-disabling
cerebral ischaemia of arterial
origin. Cerebrovasc Dis.
2000;10:147-150.
18. Diener H-C. Management
of atherothrombosis with clopidogrel
in high-risk patients with
recent TIA or ischaemic stroke
(MATCH): rationale and study
design [poster]. Poster presented
at: European Stroke Conference;
May 17, 2001; Lisbon, Portugal.
19. Easton JD. Current
advances in the management
of stroke. Neurology.
1998;51(suppl 3):S1-S2.
20. Easton JD. What
have we learned from recent
antiplatelet trials? Neurology.
1998;51(suppl 3):S36-S38.
21. Easton JD. Future
perspectives for optimizing
oral antiplatelet therapy.
Cerebrovasc Dis. 2001;11(suppl
2):23-28.
22. Goldstein LB, Bian
J, Samsa GP, Bonito AJ, Lux
LJ, Matchar DB. New transient
ischemic attack and stroke:
outpatient management by primary
care physicians. Arch Intern
Med. 2000;160:2941-2946.
23. Gorter JW, for the
Stroke Prevention In Reversible
Ischemia Trial (SPIRIT) and
European Atrial Fibrillation
Trial (EAFT) Study Groups.
Major bleeding during anticoagulation
after cerebral ischemia: patterns
and risk factors. Neurology.
1999;53:1319-1327.
24. Hennessy MJ, Britton
TC. Transient ischaemic attacks:
evaluation and management.
Int J Clin Pract. 2000;54:432-436.
25. Johnston SC, Gress
DR, Browner WS, Sidney S.
Short-term prognosis after
emergency department diagnosis
of TIA. JAMA. 2000;284:2901-2906.
26. Leys D. Atherothrombosis:
a major health burden.
Cerebrovasc Dis. 2001;11(suppl
2):1-4.
27. McCabe DJ, Brown
MM. Prevention of ischaemic
stroke-antiplatelets. Br
Med Bull. 2000;56:510-525.
28. McDonald CT, Koroshetz
WJ. Transient ischemic attack
and secondary stroke. Curr
Treat Options Neurol.
2000;2:329-342.
29. Mohr JP, Thompson
JLP, Lazar RM, et al. A comparison
of warfarin and aspirin for
the prevention of recurrent
ischemic stroke. N Engl
J Med. 2001;345:1444-1451.
30. Oddone E, Brass
LM, Booss J, et al. Quality
enhancement research initiative
in stroke: prevention, treatment,
and rehabilitation. Med
Care. 2000;38:I92-I104.
31. Sarasin FP, Gaspoz
J-M, Bounameaux H. Cost-effectiveness
of new antiplatelet regimens
used as secondary prevention
of stroke or transient ischemic
attack. Arch Intern Med.
2000;160:2773-2778.
32. Yusuf S, Reddy
S, Ounpuu S, Anand S. Global
burden of cardiovascular diseases:
part I: general considerations,
the epidemiologic transition,
risk factors, and impact of
urbanization. Circulation.
2001;104:2746-2753.
33. Yusuf S, Reddy
S, Ounpuu S, Anand S. Global
burden of cardiovascular diseases:
part II: variations in cardiovascular
disease by specific ethnic
groups and geographic regions
and prevention strategies.
Circulation. 2001;104:2855-2864.
34. Yusuf S, Zhao F, Mehta
SR, et al. Effects of clopidogrel
in addition to aspirin in
patients with acute coronary
syndromes without ST-segment
elevation. N Engl J Med.
2001;345:494-502.
For
technical support, call 1-877-893-6808,
or send an email to support@vioworks.com
|
